Health Partner Evaluation at Providence

NCT ID: NCT03443284

Last Updated: 2020-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

79 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-11

Study Completion Date

2019-12-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective, mixed methods, multi-center, randomized, comparative, controlled study. Providence Health \& Services will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Subjects will be randomized to either the treatment group (Health Partner alongside standard care) or the control group (standard care alone). Health Partner is a combination of an iPhone or iPod Touch Operating System mobile application and a health care provider portal. The primary objective is to compare care plan adherence (pre- and post-surgery) for Health Partner vs. control subjects. Secondary objectives include evaluating all-cause medical resource utilization, communication with health care provider, well-being, fear of surgery, confidence in recovery from surgery, sleep, and patient satisfaction for 90 days post-surgery. To evaluate the behavioral factors associated with care path adherence using a qualitative interview method.To evaluate the usability and preferences of patients in their interaction with the intervention using a qualitative interview method, for product development.

The total planned study duration is approximately 1 year and 7 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Knee Arthroplasty; Total Hip Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention (Health Partner)

The mobile health (mHealth) product, Health Partner for Knees and Hips (Health Partner), is a combination of an iPhone or iPod Touch Operating System (iOS) mobile application (app) and a health care provider (HCP) portal.

Group Type EXPERIMENTAL

Health Partner

Intervention Type BEHAVIORAL

Health Partner is a combination of an iPhone or iPod Touch Operating System mobile application and a health care provider portal.

Control

Patients randomized to Control will receive pre-printed brochures that outline the steps of the care plan for unilateral TKA and THA, as per standard care provided to any unilateral TJA patient receiving care at Providence Health \& Services.

Group Type OTHER

Standard Care

Intervention Type BEHAVIORAL

Patients randomized to Control will receive pre-printed brochures that outline the steps of the care plan for unilateral TKA and THA, as per standard care provided to any unilateral TJA patient receiving care at Providence Health \& Services.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Health Partner

Health Partner is a combination of an iPhone or iPod Touch Operating System mobile application and a health care provider portal.

Intervention Type BEHAVIORAL

Standard Care

Patients randomized to Control will receive pre-printed brochures that outline the steps of the care plan for unilateral TKA and THA, as per standard care provided to any unilateral TJA patient receiving care at Providence Health \& Services.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

mHealth Control

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is 18 or older at the time of consent.
* Subject must be identified by their PH \& S provider as needing elective unilateral TKA or THA.
* Subject is willing to give voluntary, written informed consent to participate in this Study prior to the scheduled TKA or THA surgery.
* Subject authorizes the transfer of his/her information to the Sponsor and Business Associate.
* Subject must have a valid e-mail address and willing to access their inbox on a regular basis.
* Subject must possess an iPhone/iPad/iPod Touch with operating iOS 9.0 or later and be willing to use and access digital materials from a mobile app.
* Subject must be able to comprehend and comply with the requirements of the Study.
* Subject must be able to speak, read and understand English fluently.

Exclusion Criteria

* Subject is not able to follow the standard of care (e.g. due to allergies) and would require special care or circumstances.
* Subject scheduled to have TKA or THA sooner than 4 weeks from the time they enrolled in the study.
* Subject is undergoing a revision to a previous surgery.
* Subject is undergoing TKA or THA following traumatic injury (i.e. fracture).
* Subject is expected to need another lower limb joint replacement (hip/knee) prior to completing this Study.
* Subject is a repeat patient and was enrolled in the study previously.
* Subject has had prior experience with the Health Partner companion app.
* Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
* Subject, in the opinion of the sub-investigator is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect his/her ability to complete patient reported questionnaires or be compliant with follow-up requirements.
* Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
* Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing activities (e.g., muscular dystrophy, multiple sclerosis, Charcot disease).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johnson & Johnson Health and Wellness Solutions, Inc.

INDUSTRY

Sponsor Role collaborator

DePuy Orthopaedics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Croy, MD

Role: PRINCIPAL_INVESTIGATOR

Providence Newberg Medical Center

Arnold Peterson, MD

Role: PRINCIPAL_INVESTIGATOR

Providence Sacred Heart/Holy Family

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Providence Newberg Medical Center

Newberg, Oregon, United States

Site Status

Providence Sacred Heart Hospital

Spokane, Washington, United States

Site Status

Providence Holy Family Hospital

Spokane, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DSJ-2017-06

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.